Search

Find exactly what you’re looking for.

Showing 1-15 of 15 results

In a conversational 30-minute forum over Zoom, Saul Ewing attorneys will host a monthly series discussing emerging industry developments and common issues that cannabis businesses face today. Interested in the full series? Find additional dates and topics . For questions, please contact Mary...

Linda Retz of Saul Ewing LLP and Elizabeth Carter, Louisiana State University School of Law Professor, will discuss how to handle intergenerational estate planning and planning involving second (and further) marriages and the inherent conflicts and ethical issues surrounding joint representation of...

Litigation and Transactional Basics Series Part 2 – A Primer on M&A Transactions and Key Corporate Governance Concepts This program will examine the basic aspects of an M&A transaction, from both the perspective of buyers and sellers, and focus on the in-house counsel’s role in leading a successful...

David Sartorio, a Partner at Saul Ewing LLP, will be one of four panelists speaking on "Mastering the Art of Sell-Side Success: Strategies, Stories and Secrets" at the Smart Business Dealmakers Conference on November 2, 2023 in Minneapolis, MN. Deal math is changing in the face of economic headwinds...

Have you ever wondered about what types of benefits and executive compensation issues you should be thinking about in M&A transactions? This presentation provides an overview of these topics and an issue spotting guide, which will be beneficial for those involved in M&A and for those who otherwise...

Please join us for an upcoming tech M&A workshop, Selling Up Selling Out: Live in Minneapolis, organized by Corum Group at our offices on Wednesday, August 9th. Saul Ewing LLP is sponsoring the half-day conference, where you can hear from former CEOs and market experts as they cover valuations...

This step-by-step practical instruction offers essential knowledge of probate processes and best practices for handling each unique case effectively. Partner Indira Sharma will lead the discussion at Step 7, focusing on probate and fiduciary litigation. This session will cover the following: Will...

The FTC has announced the annual updates to the Hart-Scott-Rodino (“HSR”) size thresholds, fees and the daily penalty for HSR violations. The updated thresholds and fees were published in the Federal Register on January 26, 2023 and will take effect on February 27, 2023. See Federal Register...

LATEST UPDATE The FTC has voted to extend the public comment period on its proposed rule to ban employers from imposing non-competes on their workers, and will now be accepting comments on the proposed rule until April 19, 2023. Comments can still be submitted in either writing or online using the...

Saul Ewing is a proud sponsor of the M&A East Conference held by the Philadelphia Chapter of the Association of Corporate Growth. M&A East attracts top strategic and financial dealmakers as well as leading middle market advisors and provides an environment for valuable networking. The conference...

FIDUCIARY LITIGATION: CONTESTED WILLS, TRUSTS, INTER VIVOS TRANSFERS AND GUARDIANSHIPS Indira Sharma, a litigator at Saul Ewing, will be presenting at the MSBA CLE entitled "Fiduciary Litigation: Contested Wills, Trusts, Inter Vivos Transfers and Guardianships." Indira will be speaking on September...

Saul Ewing LLP, a full-service law firm with attorneys in 16 offices, today announced that 59 attorneys from the Firm received the distinguished honor of being recognized for legal excellence and client service by Chambers USA 2022. Several of the Firm’s practice areas also earned high rankings...

“Penny wise but pound foolish” first appeared in writing over 500 years ago. This idiom captures the wisdom of human experience in just five words: shortcuts that appear to save money are more expensive in the long run. Sometimes much more. Further proof of this eternal truth - and one taxpayer’s...

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...

For More Information